BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33655810)

  • 1. Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?
    Franchini M; Schiavulli M; Liumbruno GM
    Expert Rev Hematol; 2021 Mar; 14(3):263-270. PubMed ID: 33655810
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of emicizumab in acquired hemophilia A: A case report.
    Yates SG; Webb CB; Sarode R; Ibrahim IF; Shen YP
    Transfus Apher Sci; 2022 Dec; 61(6):103457. PubMed ID: 35643753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
    Sakurai Y; Takeda T
    J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies.
    Marino R
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should emicizumab be used in patients with acquired hemophilia A?
    Tiede A; Kemkes-Matthes B; Knöbl P
    J Thromb Haemost; 2021 Mar; 19(3):637-644. PubMed ID: 33306259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adequate diagnosis of acquired hemophilia A].
    Casas Patarroyo CP; Agudelo López CDP; Galvez K; Lagos Ibarra J; Martínez Rojas S; Ibatá Bernal L
    Rev Med Chil; 2019 Mar; 147(3):334-341. PubMed ID: 31344171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful management of acquired hemophilia A onset during pregnancy: A case report.
    Nishi A; Muramatsu A; Maeda E; Kobayashi T; Waratani M; Kitawaki J
    J Obstet Gynaecol Res; 2021 Nov; 47(11):4060-4066. PubMed ID: 34263499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired haemophilia A: a 2013 update.
    Franchini M; Mannucci PM
    Thromb Haemost; 2013 Dec; 110(6):1114-20. PubMed ID: 24008306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding.
    Pasca S; Zanon E; Mannucci PM; Peyvandi F
    Blood Transfus; 2023 Nov; 21(6):549-556. PubMed ID: 36795341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Acquired Hemophilia A.
    Poston JN; Kruse-Jarres R
    Transfus Med Rev; 2022 Oct; 36(4):215-219. PubMed ID: 36280447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A.
    Knöbl P
    Drugs; 2018 Dec; 78(18):1861-1872. PubMed ID: 30542801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and open issues in the management of acquired hemophilia A (AHA).
    Shetty SD; Ghosh K
    Blood Cells Mol Dis; 2015 Mar; 54(3):275-80. PubMed ID: 25486929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States.
    Sharathkumar A; Mokdad AG
    Cureus; 2023 Jan; 15(1):e33927. PubMed ID: 36819387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexplained hemorrhagic syndrome? Consider acquired hemophilia A or B.
    Constantinescu C; Jitaru C; Pasca S; Dima D; Dirzu N; Coriu D; Zdziarska J; Ghiaur G; Mahlangu J; Tomuleasa C
    Blood Rev; 2022 May; 53():100907. PubMed ID: 34776294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study.
    Holstein K; Liu X; Smith A; Knöbl P; Klamroth R; Geisen U; Eichler H; Miesbach W; Tiede A
    Blood; 2020 Jul; 136(3):279-287. PubMed ID: 32268359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, laboratory aspects and management of acquired hemophilia A.
    Toschi V; Baudo F
    Intern Emerg Med; 2010 Aug; 5(4):325-33. PubMed ID: 20407848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.